Suppr超能文献

姜黄素的基础药物化学

The Essential Medicinal Chemistry of Curcumin.

作者信息

Nelson Kathryn M, Dahlin Jayme L, Bisson Jonathan, Graham James, Pauli Guido F, Walters Michael A

机构信息

Department of Medicinal Chemistry, Institute for Therapeutics Discovery and Development, University of Minnesota , Minneapolis, Minnesota 55414, United States.

Department of Pathology, Brigham and Women's Hospital , Boston, Massachusetts 02115, United States.

出版信息

J Med Chem. 2017 Mar 9;60(5):1620-1637. doi: 10.1021/acs.jmedchem.6b00975. Epub 2017 Jan 11.

Abstract

Curcumin is a constituent (up to ∼5%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double-blinded, placebo controlled clinical trial of curcumin has been successful. This manuscript reviews the essential medicinal chemistry of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead. On the basis of this in-depth evaluation, potential new directions for research on curcuminoids are discussed.

摘要

姜黄素是传统药物姜黄中的一种成分(含量高达约5%)。对姜黄治疗用途的兴趣以及姜黄素类化合物相对容易分离,促使人们对其进行了广泛研究。姜黄素最近被归类为PAINS(泛测定干扰化合物)和IMPS(无效代谢万灵药)候选物。姜黄素在体外和体内可能存在的假活性导致了超过120项针对多种疾病的姜黄素类化合物临床试验。没有一项姜黄素的双盲、安慰剂对照临床试验取得成功。本手稿综述了姜黄素的基本药物化学,并提供证据表明姜黄素是一种不稳定、具有反应性、无法被生物利用的化合物,因此极不可能成为有效先导化合物。基于这一深入评估,讨论了姜黄素类化合物研究的潜在新方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5204/5346970/3ad761609837/jm-2016-009757_0005.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验